CD8A and neoplasm: We suggest that CXCL10 attracts CD8+ T cells into the tumor, where they generate robust anti-tumor effects, although the enhanced T cell infiltration in the distant (uninfected) tumor would indicate the presence of an additional, broader immune mechanism.